Q32

Currently Open

See all Clinical Trials

A Phase 2 Study to Evaluate the Safety, Pharmacology, Pharmacokinetics, and Clinical Activity of ADX-097 in Adult Patients with Primary IgA Nephropathy, Lupus Nephritis, or C3 Glomerulopathy

Learn More

Considering a Clinical Trial?

Clinical Trials Handout

The IgA Nephropathy Foundation is working with the partners below to provide our patients access to breakthrough clinical trials. Patient participation is the key to finding treatment and the ultimate cure for IgA Nephropathy. Read more about each trial below to see if you are eligible.

Considering a Clinical Trial? View All Clinical Trials Download Handout Here